📰 Greg Canter News
Page 2 - Greg Canter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greg Canter. Real-time updates on events, politics, business and more.
September 8, 2022
In a remarkable turnaround, a panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. Patients and their families have rallied behind Amylyx's drug, urging approval.
September 7, 2022
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.
September 7, 2022
WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend...
September 7, 2022
A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.
September 7, 2022
A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...
September 7, 2022
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.
September 7, 2022
A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...
September 7, 2022
A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.
September 7, 2022
A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.
September 7, 2022
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.